XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Retained Earnings
Balances at Dec. 31, 2019 $ 60,081 $ 3 $ 255,142 $ 51 $ (195,115)
Balances (in shares) at Dec. 31, 2019   29,084      
Issuance of common stock in connection with employee stock purchase plan 174   174    
Issuance of common stock in connection with employee stock purchase plan (in shares)   26      
Issuance of common stock in connection with exercise of stock options 115   115    
Issuance of common stock in connection with exercise of stock options (in shares)   37      
Stock-based compensation expense 1,348   1,348    
Unrealized gain (loss) on marketable securities (185)     (185)  
Net loss (18,728)       (18,728)
Balances at Mar. 31, 2020 42,805 $ 3 256,779 (134) (213,843)
Balances (in shares) at Mar. 31, 2020   29,147      
Balances at Dec. 31, 2019 60,081 $ 3 255,142 51 (195,115)
Balances (in shares) at Dec. 31, 2019   29,084      
Foreign currency translation adjustment 5        
Unrealized gain (loss) on marketable securities (36)        
Net loss (58,179)        
Balances at Sep. 30, 2020 136,274 $ 5 389,543 20 (253,294)
Balances (in shares) at Sep. 30, 2020   44,692      
Balances at Mar. 31, 2020 42,805 $ 3 256,779 (134) (213,843)
Balances (in shares) at Mar. 31, 2020   29,147      
Issuance of common stock in connection with exercise of stock options 44   44    
Issuance of common stock in connection with exercise of stock options (in shares)   10      
Issuance of common stock and pre-funded warrants in connection with public offering, net of offering costs 129,054 $ 2 129,052    
Issuance of common stock and pre-funded warrants in connection with public offering, net of offering costs (in shares)   15,443      
Stock-based compensation expense 1,600   1,600    
Unrealized gain (loss) on marketable securities 173     173  
Net loss (21,418)       (21,418)
Balances at Jun. 30, 2020 152,258 $ 5 387,475 39 (235,261)
Balances (in shares) at Jun. 30, 2020   44,600      
Offering costs in connection with public offering (39)   (39)    
Issuance of common stock in connection with employee stock purchase plan 192   192    
Issuance of common stock in connection with employee stock purchase plan (in shares)   34      
Issuance of common stock in connection with exercise of stock options 219   219    
Issuance of common stock in connection with exercise of stock options (in shares)   58      
Stock-based compensation expense 1,696   1,696    
Foreign currency translation adjustment 5     5  
Unrealized gain (loss) on marketable securities (24)     (24)  
Net loss (18,033)       (18,033)
Balances at Sep. 30, 2020 136,274 $ 5 389,543 20 (253,294)
Balances (in shares) at Sep. 30, 2020   44,692      
Balances at Dec. 31, 2020 139,832 $ 5 415,824 11 (276,008)
Balances (in shares) at Dec. 31, 2020   47,959      
Issuance of common stock in connection with employee stock purchase plan 224   224    
Issuance of common stock in connection with employee stock purchase plan (in shares)   38      
Issuance of common stock in connection with exercise of stock options 146   146    
Issuance of common stock in connection with exercise of stock options (in shares)   23      
Issuance of common stock and pre-funded warrants in connection with public offering, net of offering costs (in shares)   1,000      
Stock-based compensation expense 1,757   1,757    
Foreign currency translation adjustment 4     4  
Unrealized gain (loss) on marketable securities 10     10  
Net loss (18,218)       (18,218)
Balances at Mar. 31, 2021 123,755 $ 5 417,951 25 (294,226)
Balances (in shares) at Mar. 31, 2021   49,020      
Balances at Dec. 31, 2020 139,832 $ 5 415,824 11 (276,008)
Balances (in shares) at Dec. 31, 2020   47,959      
Foreign currency translation adjustment (4)        
Unrealized gain (loss) on marketable securities (5)        
Net loss (45,355)        
Balances at Sep. 30, 2021 102,081 $ 5 423,437 2 (321,363)
Balances (in shares) at Sep. 30, 2021   49,306      
Balances at Mar. 31, 2021 123,755 $ 5 417,951 25 (294,226)
Balances (in shares) at Mar. 31, 2021   49,020      
Issuance of common stock in connection with exercise of stock options 33   33    
Issuance of common stock in connection with exercise of stock options (in shares)   6      
Stock-based compensation expense 2,080   2,080    
Foreign currency translation adjustment 2     2  
Unrealized gain (loss) on marketable securities (16)     (16)  
Net loss (6,830)       (6,830)
Balances at Jun. 30, 2021 119,024 $ 5 420,064 11 (301,056)
Balances (in shares) at Jun. 30, 2021   49,026      
Issuance of common stock in connection with employee stock purchase plan 230   230    
Issuance of common stock in connection with employee stock purchase plan (in shares)   45      
Issuance of common stock in connection with exercise of stock options 1,036   1,036    
Issuance of common stock in connection with exercise of stock options (in shares)   235      
Stock-based compensation expense 2,107   2,107    
Foreign currency translation adjustment (10)     (10)  
Unrealized gain (loss) on marketable securities 1     1  
Net loss (20,307)       (20,307)
Balances at Sep. 30, 2021 $ 102,081 $ 5 $ 423,437 $ 2 $ (321,363)
Balances (in shares) at Sep. 30, 2021   49,306